Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Pan American Silver
PAAS
$22.5B
| $7.76M | 0.01% |
531,765
-22,419
| -4% | -$321K |
|
1277
CALL
Teleflex
TFX
$5.94B
| $7.75M | 0.01% |
30,000
-10,000
| -25% | -$2.53M |
|
|
MDP
1278
DELISTED
Meredith Corporation
MDP
| $7.74M | 0.01% |
149,017
+144,373
| +3,109% | +$7.83M |
|
1279
E.W. Scripps
SSP
$305M
| $7.72M | 0.01% |
491,058
+328,736
| +203% | +$5.49M |
|
1280
PUT
LyondellBasell Industries
LYB
$20.2B
| $7.72M | 0.01% |
92,800
+24,000
| +35% | +$2.2M |
|
1281
Arch Capital
ACGL
$34.3B
| $7.66M | 0.01% |
286,546
-10,499
| -4% | -$290K |
|
1282
Conduent
CNDT
$253M
| $7.66M | 0.01% |
720,306
+43,900
| +6% | +$684K |
|
1283
Herc Holdings
HRI
$5.22B
| $7.64M | 0.01% |
293,912
+192,891
| +191% | +$6.73M |
|
1284
Astronics
ATRO
$3.2B
| $7.61M | 0.01% |
299,934
+109,204
| +57% | +$2.88M |
|
1285
TSMC
TSM
$2.16T
| $7.61M | 0.01% |
206,206
-1,393,569
| -87% | -$53M |
|
|
RETA
1286
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.61M | 0.01% |
135,658
+36,116
| +36% | +$2.21M |
|
1287
Fresenius Medical Care
FMS
$12.5B
| $7.6M | 0.01% |
+234,680
| New | +$9.47M |
|
1288
Enviri
NVRI
$609M
| $7.59M | 0.01% |
382,414
+320,204
| +515% | +$7.94M |
|
|
AMRN
1289
CALL
Amarin Corp
AMRN
$299M
| $7.58M | 0.01% |
27,835
+10,335
| +59% | +$3.77M |
|
|
CATM
1290
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $7.56M | 0.01% |
290,939
-343,904
| -54% | -$10.4M |
|
1291
Ecopetrol
EC
$34.5B
| $7.55M | 0.01% |
475,261
+374,080
| +370% | +$8.03M |
|
1292
Fate Therapeutics
FATE
$306M
| $7.54M | 0.01% |
587,640
+428,399
| +269% | +$5.97M |
|
1293
Atkore
ATKR
$3.16B
| $7.53M | 0.01% |
379,743
-679,488
| -64% | -$14.2M |
|
1294
Papa John's
PZZA
$794M
| $7.53M | 0.01% |
189,105
-233,415
| -55% | -$11.8M |
|
|
FTACU
1295
DELISTED
FinTech Acquisition Corp. III Unit
FTACU
| $7.52M | 0.01% |
+750,000
| New | +$7.52M |
|
|
AAMI
1296
Acadian Asset Management
AAMI
$3.32B
| $7.51M | 0.01% |
703,198
-138,811
| -16% | -$1.67M |
|
|
RARX
1297
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7.5M | 0.01% |
412,066
+330,788
| +407% | +$5.19M |
|
|
DENN
1298
DELISTED
Denny's
DENN
| $7.49M | 0.01% |
462,051
+302,473
| +190% | +$4.76M |
|
1299
WaFd
WAFD
$2.68B
| $7.49M | 0.01% |
280,316
+54,625
| +24% | +$1.53M |
|
|
NVTA
1300
DELISTED
Invitae Corporation
NVTA
| $7.48M | 0.01% |
676,015
+439,916
| +186% | +$5.7M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.